Companies List
>> Merck
Merck & Co., Inc. (Merck) is a global pharmaceutical company that discovers, develops, manufactures and markets a range of products to improve human and animal health. The Company's operations consist of two segments: the Pharmaceutical segment and the Vaccines segment. The Pharmaceutical segment includes human health pharmaceutical products marketed either directly or through joint ventures. These products consist of therapeutic and preventive agents, sold by prescription, for the treatment of human disorders. The Vaccines segment includes human health vaccine products marketed either directly or through a joint venture. These products consist of preventative pediatric, adolescent and adult vaccines, primarily administered at physician offices.
Official website:
www.merck.com
Companies List
>> Merck
Merck KGaA is a global pharmaceutical and chemical company, which operates in two business sectors. The Pharmaceuticals business sector offers prescription and patented drugs for the treatment of health conditions that include cancer, metabolic disorders and cardiovascular diseases, as well as offering generic and over-the-counter drugs and remedies. The Ethicals division of the business sector focuses on the development of oncology products. Merck's Chemicals business sector offers chemicals for high-technology applications, such as components for liquid crystal displays, light-emitting materials, effect pigments for industry and cosmetics, and analytical reagents and test kits for industry, research laboratories and environmental analysis.
Official website:
www.merck.de
|
|
 |
|
USA stock market daily report by Millenium Traders (October 9, 2008, Thursday, 10.30 p.m. GMT), 9 October 2008
USA stock market daily report by Millenium Traders (October 8, 2008, Wednesday, 10.30 p.m. GMT), 8 October 2008
USA stock market daily report by Millenium Traders (October 7, 2008, Tuesday, 10.30 p.m. GMT), 7 October 2008
|
|
Verint Systems price target reduced, 7 December 2007
Thomas Weisel upgraded Intel to "overweight", 6 December 2007
UBS upgraded price target on Exxon Mobil to $96, 21 November 2007
|
|
|
|
|
|
 |
|
Indian stock market morning report by Keynote Capitals (October 10, 2008, Friday, 7.00 a.m. GMT), 10 October 2008
Indian stock market morning report by Keynote Capitals (October 8, 2008, Wednesday, 7.00 a.m. GMT), 8 October 2008
Indian stock market morning report by Keynote Capitals (October 7, 2008, Tuesday, 6.00 a.m. GMT), 7 October 2008
|
|
Keynote Capitals maintain "buy" recommendation on Pyramid Saimira Theatre, 5 February 2008
Keynote Capitals recommends to buy Euro Ceramics Ltd., 5 February 2008
Keynote Capitals recommends to buy Pyramid Saimira Theatre, 13 December 2007
|
|
|
|
|
|
 |
|
Russian stock market morning report by Veles Capital (October 8, 2008, Wednesday, 7.30 a.m. GMT), 8 October 2008
Russian stock market morning report by Veles Capital (October 7, 2008, Tuesday, 7.30 a.m. GMT), 7 October 2008
Russian stock market morning report by Veles Capital (October 6, 2008, Monday, 7.30 a.m. GMT), 6 October 2008
|
|
Veles Capital upgraded price target on Rosneft from $14.31 to $15.11, recommendation "buy" unchanged, 18 September 2008
Veles Capital set price target of $5.75 on NLMK, recommenation - "buy", 17 September 2008
Veles Capital reduced price target on Lukoil from $138.44 to $129.63, recommendation "buy" unchanged, 15 September 2008
|
|
|
|
|
|
